Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database
Conclusions:
In a large population of elderly U.S. adults undergoing lumbar arthrodesis, BMP use was not associated with cancer risk or mortality.
Level of Evidence:
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Source: JBJS - Category: Orthopaedics Authors: Beachler, D. C., Yanik, E. L., Martin, B. I., Pfeiffer, R. M., Mirza, S. K., Deyo, R. A., Engels, E. A. Tags: Spine Scientific Articles Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | Medicare | Orthopaedics | Study